Who owns Seres Therapeutics Inc?
- Ticker: MCRB
- CUSIP Number: 81750r201
Tip: Access positions for across all investors
Analyze quarterly positions in Seres Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Seres Therapeutics stock
Who bought or sold Seres Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Flagship Ventures Management | 1.2M | $10M | 0% | Mar 2026 |
|
| Susquehanna International | 333k | $5.0M | -15% | Dec 2025 |
|
| Vanguard Group | 324k | $4.8M | 4% | Dec 2025 |
|
| Vanguard Capital Management | 294k | $2.6M | 100% | Mar 2026 |
|
| Vontobel Holding | 139k | $1.2M | 34% | Mar 2026 |
|
| Marshall Wace | 120k | $1.8M | -4% | Dec 2025 |
|
| BlackRock | 102k | $905k | -2% | Mar 2026 |
|
| Caption Management | 75k | $1.1M | 0% | Dec 2025 |
|
| Geode Capital Management | 75k | $664k | -13% | Mar 2026 |
|
| Citadel Advisors | 60k | $528k | -20% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 40k | $352k | 100% | Mar 2026 |
|
| State Street Corporation | 34k | $504k | 14% | Dec 2025 |
|
| Lion Point Capital | 32k | $280k | 0% | Mar 2026 |
|
| Charles Schwab Investment Management | 31k | $467k | 0% | Dec 2025 |
|
| Morgan Stanley | 22k | $193k | -14% | Mar 2026 |
|
| Two Sigma Investments | 19k | $167k | -27% | Mar 2026 |
|
| American Century Companies | 16k | $242k | 100% | Dec 2025 |
|
| Northern Trust | 15k | $220k | 22% | Dec 2025 |
|
| Invesco | 15k | $129k | 1% | Mar 2026 |
|
| Barclays | 7.4k | $111k | 428% | Dec 2025 |
|
| UBS Group | 7.0k | $62k | 66% | Mar 2026 |
|
| SBI Securities | 3.5k | $31k | 0% | Mar 2026 |
|
| Vanguard Global Advisers | 2.0k | $18k | 100% | Mar 2026 |
|
| FMR | 1.7k | $26k | -8% | Dec 2025 |
|
| Rachor Investment Advisory Services | 1.5k | $13k | 0% | Mar 2026 |
|
| Simplex Trading | 1.2k | $18k | -56% | Dec 2025 |
|
| Group One Trading | 824.00 | $7.3k | 100% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 211.00 | $1.9k | -73% | Mar 2026 |
|
| UMA Financial Services | 142.00 | $1.3k | 0% | Mar 2026 |
|
| Royal Bank of Canada | 107.00 | $1.1k | -64% | Mar 2026 |
|
| Wells Fargo & Company | 10.00 | $89.000000 | -96% | Mar 2026 |
|
| Sound Income Strategies | 8.00 | $71.000000 | 0% | Mar 2026 |
|
| Advisor Group Holdings | 8.00 | $119.000000 | 0% | Dec 2025 |
|
| SRS Capital Advisors | 6.00 | $18.000000 | 200% | Mar 2026 |
|
| Hanson McClain Advisors | 4.00 | $60.000000 | 100% | Dec 2025 |
|
Who sold out of Seres Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| J. Goldman & Co | Sep 2025 | 89k | $1.7M |
| 683 Capital Management | Dec 2025 | 52k | $778k |
| Jane Street | Dec 2025 | 30k | $445k |
| Schonfeld Strategic Advisors | Dec 2025 | 29k | $433k |
| OMERS Administration Corporation | Dec 2025 | 14k | $214k |
| Goldman Sachs Group | Dec 2025 | 14k | $213k |
| ExodusPoint Capital Management | Dec 2025 | 13k | $190k |
| Jpmorgan Chase & Co | Sep 2025 | 65.00 | $1.3k |
| Us Bancorp | Sep 2025 | 12.00 | $231.000000 |